CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1
First Claim
Patent Images
1. At least one peptide consisting essentially of an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1 to SEQ ID NO;
18.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.
-
Citations
27 Claims
- 1. At least one peptide consisting essentially of an amino acid sequence selected from the group consisting of SEQ ID NO:
-
26. A tumor associated peptide consisting of or essentially consisting of an amino acid sequence selected from SEQ ID NO:
- 5 and/or SEQ ID NO;
6.
- 5 and/or SEQ ID NO;
Specification